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Abstract
Background: Wheezing is a common symptom in early childhood. However, refractory wheezing is difficult to
treat, and it may thus account for extensive use of medical resources. It is therefore important to improve our
understanding of the pathophysiology of refractory childhood wheezing.
Methods: In this descriptive study, we studied 156 children with refractory wheezing using fiberoptic bronchoscopy
and bronchoalveolar lavage (BAL), and compared the results with a control group of 46 children with various
pulmonary diseases but no wheezing. Etiology and cell classification were analyzed for each BAL sample.
Results: Overall, 21.8 % of children with refractory wheezing had airway malformations including tracheomalacia,
airway stenosis, and tracheal bronchus. The incidence of airway malformations increased to 31 % in infants under
12 months of age. A significant increase in neutrophil ratio and decrease in macrophage ratio were observed in BAL
from children with refractory wheezing compared with controls. Pathogen infection led to a higher ratio of neutrophils
in the wheezing group compared with controls. However, there were no significant differences in neutrophil ratios
among children with various pathogen infections. Furthermore, children with refractory wheezing had a high rate of
Mycoplasma pneumoniae infection.
Conclusions: Airway malformations might play an important role in children under 3 years of age with refractory
wheezing, especially in infants under 12 months of age. Neutrophil-mediated airway inflammation was characteristic of
refractory wheezing in children under 3 years of age. In addition, infections such as M. pneumoniae may aggravate
airway inflammation and affect refractory wheezing.
Keywords: Bronchoalveolar lavage, Neutrophil-mediated inflammation, Infant, Refractory wheezing, Airway
malformation
Abbreviations: BAL, Bronchoalveolar lavage; ECP, Eosinophil cationic protein; FB, Fiberoptic bronchoscopy
Background
Wheezing in early childhood is a common but poorly
characterized symptom, with a third of infants reported
to experience multiple episodes of wheezing in their
first 3 years [1]. Lower-airway inflammation, especially
neutrophil-mediated inflammation, occurs in young
children with recurrent wheezing [2, 3]. Compared with
recurrent wheezing, refractory wheezing is more diffi-
cult to treat effectively and often accounts for extensive
use of medical resources. It is therefore important to
improve our understanding of the pathophysiology of
refractory wheezing.
Congenital malformations of the lungs and airways are
among several causes of irreversible airway obstruction
in children who may develop various symptoms such as
recurrent wheezing, cough, recurrent lower airway infec-
tion, severe dyspnea, and respiratory insufficiency [4–7].
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We speculate that airway morphology may play an im-
portant role in refractory wheezing.
Fiberoptic bronchoscopy (FB) and bronchoalveolar lav-
age (BAL) are indispensable techniques for investigating
pediatric patients with airway abnormalities and pul-
monary infiltrates, and both are carried out as routine
procedures in many health centers [8]. The aim of this
study was to determine the cellular profile of BAL from
infants with refractory wheezing in the Suzhou area,
China, and to investigate airway malformations and neu-
trophil ratios to determine if ongoing inflammation plays
a role in the development of this condition.
Methods
Inclusion and exclusion criteria
This descriptive, retrospective study enrolled children
under 3 years of age with refractory wheezing, defined as
persistent wheezing requiring at least 4 weeks of oral cor-
ticosteroid treatment after poor responses to an initial in-
haled combination of corticosteroids and bronchodilators.
Additionally, the symptom-free time during which chil-
dren had no wheezing symptoms was no longer than
3 days in the study population. Children were excluded
from the study group if they met any of the following
conditions: 1) wheezing symptoms lasted for <1 month;
2) had an apparent recovery period; 3) were severely
sick and unable to tolerate FB; 4) had a family history
of smoking; and 5) were premature or low birthweight
babies. All the participants’ parents or guardians gave
their written informed consent for participation in the
study. The study was approved by the ethics committee
of Soochow University.
Children with wheezing
Based on the inclusion and exclusion criteria, 156 chil-
dren with wheezing who were hospitalized in the Chil-
dren’s Hospital of Soochow University, China, from
September 2011 to May 2014 were chosen for this
study. All included patients received oral steroids. A
wheezing infant was considered to be atopic if they
had a strong family history of atopy (two or more dir-
ect relatives with atopy), atopic dermatitis, or a prior
positive allergen test consisting of a prick test with an
allergen on the skin or a radioallergosorbent test.
Control group
There are ethical problems associated with conducting
BAL cell analysis in healthy children. The control group
therefore consisted of children sampled during the same
period with the following conditions, in which the BAL
cell analysis was relatively normal: 1) recurrent bron-
chitis without wheezing (n = 11); 2) persistent pulmonary
atelectasis for at least 1 month (n = 3); 3) suspicion of
foreign-body aspiration (n = 7); 4) persistent cough and
final diagnosis of psychogenic cough (n = 12); 5) persist-
ent laryngeal stridor with suspected laryngomalacia (n =
10); or 6) hemoptysis with suspected lung disease and
final diagnosis of epistaxis (n = 3). Children in the first
three groups underwent FB during remission. Children
were excluded from the control group if they met any
of the following criteria: 1) history of wheezing; 2)
endoscopic bronchial inflammation; 3) endoscopic air-
way malformation; and/or 4) personal or familial his-
tory of atopy.
Initial evaluation
Demographic, clinical, and laboratory data were col-
lected after admission. White blood cell count, platelets,
neutrophil ratio, and lymphocyte ratio were tested
within 4 h after admission.
Fiberoptic bronchoscopy
Parents/guardians were informed about the surgical risks
of FB and signed consent was obtained prior to the pro-
cedure. Children were fasted for both solids and liquids
for at least 6 h prior to the procedure. Intramuscular at-
ropine sulfate 0.01–0.02 mg/kg and midazolam 0.2–
0.4 mg/kg were administered as premedication. Upper
and lower airway anesthesia was achieved with 2 % lido-
caine. A flexible bronchoscope (Olympus CV260, Tokyo,
Japan or Fujinon EB-270P, Miyoshi, Japan) was wedged
into each lobe. The airways were washed three times
with 1 ml/kg of prewarmed sterile 0.9 % saline solution,
which was then collected by a sterile sputum-collecting
pipe (Falcon 50 ml, Becton-Dickinson, Rutherford, NJ,
USA). The collected BAL was used for cell counts, viral
analysis, and microbiological analysis (bacteria and
Mycoplasma pneumoniae).
Cell counts
Differential cell counts were obtained using a modified
version of Wright–Giemsa staining (Wright–Giemsa Stain,
Baso Diagnostics Inc., Taiwan, China). At least 500 cells
were examined for each specimen. The ratios of various
cell types in total cell counts were reported.
Microbiological analysis
BAL samples from wheezing and control children were
tested for 10 types of viruses and bacteria, as well as M.
pneumoniae. Bacteria were tested by inoculating BAL
onto blood plates and examining them after incubation
for 18–20 h. Bacterial growth >103 colony-forming
units/ml was considered significant. Viruses, including
respiratory syncytial virus, adenovirus, influenza virus
(A, B), and parainfluenza virus (1, 2, 3) were investigated
by immunofluorescence tests using D3 Ultra Respiratory
Virus Screening and LD Kit (Diagnostic Hybrids, OH,
USA). Positive results were defined as more than five
Gu et al. BMC Pediatrics  (2016) 16:145 Page 2 of 7
inclusion bodies detected under a fluorescence micro-
scope. M. pneumoniae and viruses including rhino-
virus, human metapneumovirus, and bocavirus were
examined by polymerase chain reaction using a Nu-
cleic Acid Amplification Fluorescent Reagent Kit (Ann
Gene Co., Guangdong, China) according to the manu-
facturer’s instructions.
Statistical analysis
Cell counts were presented as the mean ± standard devi-
ation (SD) and as medians (25 % to 75 %). The wheezing
and control groups were compared using nonparametric
Mann–Whitney two-sample U-tests, and Mann–Whitney
U-tests were used for unpaired data. χ2 tests were used for




Overall, 5830 children under 3 years old were hospital-
ized because of wheezing between September 2011 and
May 2014. Among these, 356 had refractory wheezing
for at least 4 weeks (6.1 %), 54 had an apparent recovery
period, 120 had a family history of smoking, and 32 were
premature or low-birthweight babies. According to the
exclusion criteria, 156 children with refractory wheezing
were ultimately enrolled in the study (age range, 3–36
months; mean ± SD, 13.68 ± 7.08 months), of whom 121
(77.6 %) were male. The control group was aged 1–36
months (mean ± SD, 13.08 ± 10.56 months), including 35
male children (76.1 %). The age, sex ratio, and weight
were similar in the wheezing and control groups (P >
0.05). The white blood cell count was significantly higher
in the wheezing group compared with the control group
(11.44 ± 4.97 vs 10.39 ± 4.28, P < 0.001). The neutrophil
ratio was significantly higher and the lymphocyte ratio
significantly lower in the wheezing group compared with
the controls (36.82 ± 14.97 vs 29.00 ± 13.47 and 53.38 ±
14.38 vs 60.31 ± 13.22, respectively, P < 0.001). The blood
platelet count was significantly higher in the wheezing
group compared with the controls (394.44 ± 120.19 vs
381.48 ± 131.09, respectively, P < 0.001) (Table 1).
Fiberoptic bronchoscopy findings
FB and BAL were well tolerated by both groups of chil-
dren, and no major complications were observed. Thirty-
four children (21.8 %) in the wheezing group had airway
malformations including tracheomalacia (n = 24), airway
stenosis (n = 6), and tracheal bronchus (n = 7). Among
these 34 had airway malformations, 28 (82.4 %) were male
and 27 (79.4 %) were under 12 months of age.
We further studied the characteristics of the airway in-
flammation in the wheezing group. A previous study re-
ported that airway malformation alone could cause
refractory childhood wheezing [4], and that these chil-
dren might not have typical airway inflammation. We
therefore analyzed the cellular contents of BAL from
children with refractory wheezing without airway mal-
formation and compared the results with the control
group. We also performed a subject-to-subject compari-
son in the wheezing group.
The median recovery rate was 70 % (range, 45 %–
80 %), with very little variation between the two com-
pared groups. However, the recovered cell ratio showed
a wide distribution in the wheezing group (Table 2).
Comparison between wheezing and control subjects
The neutrophil ratio was significantly higher (31.26 ±
28.10 % vs 6.38 ± 6.59 %, respectively, P < 0.001) and the
macrophage ratio was significantly lower (60.80 ±
29.20 % vs 87.06 ± 8.22 %, respectively, P < 0.001) in the
wheezing group compared with the control group. The
eosinophil ratio was also higher in the wheezing group
(0.75 ± 2.76 % vs 0.08 ± 0.27 %, respectively, P = 0.040).
There was no significant difference in BAL lymphocyte
ratio between the two groups.
Comparisons within the wheezing group
Eighty-one of 122 (66.4 %) wheezing children were
atopic and had no airway malformations. There was no
significant difference in the ratio of macrophages, lym-
phocytes, eosinophils, or neutrophils in the BAL be-
tween atopic and nonatopic children in the wheezing
group (Table 3).
In terms of pathogen analysis, we performed viral ana-
lysis, and M. pneumoniae and microbiological cultures
for the wheezing and control groups. No pathogens were
detected in the control group. Virus detection was posi-
tive in 17 (13.9 %) of the wheezing children without air-
way malformations, and microbiological findings were
positive in 78 (63.9 %). Among them, M. pneumoniae
showed the highest detection rate (n = 63, 51.6 %). In







Age, months 13.68 ± 7.08 13.08 ± 10.56 0.262
Sex, M/F 121/35 35/11 0.843
Weight, kg 10.56 ± 2.13 9.74 ± 3.72 0.115
Breastfeeding, Y/N 98/58 35/11 0.095
Whole blood cell analysis
White blood cell, ×109 11.44 ± 4.97 10.39 ± 4.28 <0.001
Neutrophils, % 36.82 ± 14.97 29.00 ± 13.47 <0.001
Lymphocytes, % 53.38 ± 14.38 60.31 ± 13.22 <0.001
Blood platelet, ×109 394.44 ± 120.19 381.48 ± 131.09 <0.001
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addition, other bacteria were detected in 30 wheezing chil-
dren (24.6 %), including Haemophilus influenzae (n = 12),
Streptococcus pneumoniae (n = 12), Escherichia coli (n =
2), Burkholderia cepacia (n = 1), Pseudomonas aeruginosa
(n = 1), Serratia marcescens (n = 1), and Enterobacter aero-
genes (n = 1).
We further investigated how the BAL cellular content
was affected by pathogens by categorizing wheezing chil-
dren into three groups: 1) non-infection group (N, n =
40), no pathogens detected; 2) bacterial-infection group
(B, n = 78), bacterial infection detected (including M.
pneumoniae); and (3) virus-infection group (V, n = 17),
virus infection detected. We then compared the BAL
cellular content between each of these groups and the
control group (C, n = 46) (Fig. 1). The lowest neutrophil
ratio was found in the control group, followed by the
non-infection group, with the highest neutrophil ratios
in the infection groups. There was no significant differ-
ence among the various bacterial ratios. The highest al-
veolar macrophage ratio was found in the control group,
and the lowest in the infection groups, while the eosino-
phil ratio was highest in the infection groups. Of note,
there was no significant difference in lymphocyte ratios
among the four groups.
Discussion
Wheezing is a common clinical symptom in infants. Its
long disease course, slow recovery, and risk of relapse
mean that refractory wheezing is difficult to treat, resulting
in high medical-resource utilization. In our department,
6.1 % of children under 3 years of age had refractory
wheezing for at least 4 weeks. Although various treatments
have been used, including inhaled and systemic corticoste-
roids, and montelukast, they have little effect on preventing
the recurrence of refractory wheezing [9]. These medica-
tions may influence eosinophilic airway inflammation but
have limited impact on noneosinophilic airway inflam-
mation. It has therefore been speculated that refrac-
tory wheezing may have a different pathophysiologic
mechanism.
Airway malformation is one cause of irreversible air-
way obstruction in children and is accompanied by many
clinical symptoms [10]. The incidence of congenital pul-
monary airway malformation is one per 8300–35,000. It
usually affects a single lobe and has no sex bias [11]. In
this study, 21.8 % of children with refractory wheezing
had airway malformations including tracheomalacia, air-
way stenosis, and tracheal bronchus, and 27 of 87 (31 %)
wheezing children under 12 months of age had airway
malformations, suggesting that airway malformations
may play an important role in refractory wheezing.
A literature search [12, 13] revealed differing total
BAL cell counts, though they generally fell within the
range 0.5–57.1 × 104/ml. Of the total BAL cells, >85 %
are alveolar macrophages, <12 % are lymphocytes, <2 %
are neutrophils, and <1 % are eosinophils [8, 10]. The
classification of BAL cells in pathological conditions var-
ies, and BAL analysis can provide important reference
information on the nature of lung diseases, the inflam-
mation process, and disease activity. BAL fluid analysis
has recently been used globally for diagnostic and prog-
nostic purposes, and to observe the curative effect of re-
spiratory disease treatments. However, although it is
theoretically important to study the cellular profile of
BAL in healthy children, this is ethically difficult. We
therefore used BAL from relatively normal children as a
control, as in previous studies [3]. BAL cell analysis in
our control group was comparable to that reported for
healthy children [3], suggesting that the results in the
control group were representative of the endotracheal
cell ratio in a normal child. In the current study, we
compared the BAL inflammatory cell profiles between
Table 2 BAL cellular contents in children with refractory wheezing and controlsa
Refractory wheezing children without airway malformation (n = 122) Control group (n = 46) P value
Alveolar macrophages, % 60.80 ± 29.20, 67 (35.0 ~ 88.25) 87.06 ± 8.22, 90 (82.5 ~ 93.0) <0.001
Lymphocytes, % 7.20 ± 6.46, 5 (2.0–10.0) 6.48 ± 5.52, 5 (2.0 ~ 8.0) 0.314
Neutrophils, % 31.26 ± 28.10, 25 (6.0 ~ 49.25) 6.38 ± 6.59, 4 (2.0 ~ 9.0) <0.001
Eosinophils, % 0.75 ± 2.76, 0.0 (0.0 ~ 0.0) 0.08 ± 0.27, 0.0 (0.0 ~ 0.0) 0.040
aData presented as mean ± SD, median (25th to 75th percentiles)
Table 3 BAL cellular content in atopic and nonatopic childrena
Variables Atopic children (n = 81) Nonatopic children (n = 41) P value
Alveolar macrophages, % 56.86 ± 30.28, 61.0(33.5 ~ 85.5) 68.56 ± 25.60, 77.0 (53.5 ~ 90.0) 0.052
Lymphocytes, % 7.75 ± 7.28, 5.0 (2.0 ~ 12.0) 6.10 ± 4.30, 5.0 (2.0 ~ 10.0) 0.366
Neutrophils, % 34.89 ± 29.61, 30.0 (7.0 ~ 54.0) 24.10 ± 23.57, 15.0 (5.0 ~ 35.5) 0.062
Eosinophils, % 0.51 ± 1.28, 0.0 (0.0 ~ 0.0) 1.24 ± 4.40, 0.0 (0.0 ~ 0.0) 0.305
aData presented as mean ± SD, median (25th to 75th percentiles)
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122 children with severe refractory wheezing and 46
control children. The BAL neutrophil ratio was signifi-
cantly increased and the macrophage ratio was signifi-
cantly decreased in the wheezing group compared with
controls, suggesting that granulocytes contribute to air-
way inflammation. The mechanism of neutrophil influx
and activation may be mediated by interleukin (IL)-8 se-
cretion [14]. Studies on neutrophilic inflammation and
persistent asthma by Gibson et al. revealed that sputum
IL-8 levels were higher in patients with noneosinophilic
asthma [15]. Neutrophils showed a close correlation with
IL-8 levels [15]. Similarly, neutrophil levels were signifi-
cantly higher in 83 wheezing infants compared with 10
control subjects [3]. Marguet et al. compared BAL cell
profiles in children with asthma, infantile wheeze, chronic
cough, and cystic fibrosis, and reported a significantly
higher level of neutrophils in wheezing infants [2].
Previous studies indicated that airway virus infection and
bacterial colonization can increase the risk of wheezing [16,
17]. In this study, virus detection was positive in 17 children
with refractory wheezing and no airway malformation,
but who had the highest bocavirus ratios. M. pneumo-
niae was positive in 63 wheezing children, and other
culture findings were positive in 30 wheezing children.
The M. pneumoniae infection rate was high in children
with refractory wheezing in the current study, and pre-
vious studies also suggested that M. pneumoniae could
cause childhood wheezing [18, 19]. However, the M.
pneumoniae status in infants is often ignored in clinical
practice. These results suggest that children with
refractory wheezing should be prescribed macrolides to
treat M. pneumoniae infection and help reduce clinical
symptoms.
A high level of neutrophils in the BAL might correlate
with infection. The relationships between various BAL
cells counts and infection indicated a significantly higher
neutrophil ratio and lower alveolar macrophage ratio
in children with refractory wheezing compared with
the control group, but this result was not affected by
pathogen infection. However, children with a patho-
genic infection had a higher neutrophil ratio and lower
alveolar macrophage ratio than those without positive
pathogen detection. We speculated that neutrophil-
mediated chronic inflammation in the airways may also
play an important role in refractory wheezing, regard-
less of pathogen infection, though infection may po-
tentially aggravate the airway inflammation.
Irrespective of the pathogens, the neutrophil ratio was
always higher in infected compared with uninfected chil-
dren. Furthermore, there was no difference in neutrophil
numbers between those infected with bacteria (including
M. pneumoniae) or virus. Bacteria, viruses, and M. pneu-
moniae have been shown to increase the BAL neutrophil
ratio. A previous study [20] found that BAL neutrophilia
was associated with bacterial pulmonary infection. The
neutrophil ratio has shown a tendency to increase with
the occurrence of viral infection [21, 22]. This may be
correlated with IL-8 and leukotriene B4, which favor the
recruitment of neutrophils in airways [23–25]. M. pneu-
moniae has been studied intensively in recent years, and
Fig. 1 BAL cellular content. The percentages of neutrophils (a), alveolar macrophages (b), lymphocytes (c) and eosinophils (d) in the BAL in the
control (C, n = 46), non-pathogen (N, n = 40), bacterial-infection (including M. pneumoniae) (B, n = 78), and virus-infection groups (V, n = 17).
Horizontal bars indicate the median for each group of patients
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children with M. pneumoniae infection had an increased
BAL cell count, which was attributed to an increase in
neutrophils [26]. In contrast, other previous studies indi-
cated that the BAL neutrophil ratio was not correlated
with bacteriological results, implying that neutrophil-
mediated inflammation was independent of bacterial in-
fection [2, 3, 27] in wheezy infants.
Cellular BAL levels may be related to allergy. In our
study, wheezing children were further categorized as
atopic or nonatopic, and there were no significant differ-
ences in cell counts (macrophages, lymphocytes, eosino-
phils, and neutrophils) between the atopic and nonatopic
groups. This was similar to the results of Le Bourgeois et
al. [3], who observed normal BAL cell levels in atopic chil-
dren. However, other studies revealed that children with
atopy had higher eosinophil levels [2]. Marguet et al. [2]
reported that eosinophils, which are characteristic of
asthma, were rarely seen in wheezing infants. However,
normal eosinophil levels do not exclude the possibility of
their involvement in the physiopathology of atopic wheez-
ing, and further studies are needed to examine the roles of
activated and degranulated eosinophils. Eosinophil cat-
ionic protein (ECP) is released by activated eosinophils
and is used as a marker of eosinophilic inflammation.
High ECP levels have been reported in patients with active
asthma and other allergic diseases [28]. The detection of
ECP levels in BAL would thus be valuable [29].
Conclusions
It is important to identify the causes associated with the
pathogenesis of refractory wheezing in children. In this
descriptive study, some children with refractory wheezing
had airway malformations, with children under 12 months
of age having a particularly high proportion of airway
anomalies. Neutrophil-mediated airway inflammation
might also play an important role in the pathophysi-
ology of refractory wheezing, while infections might
aggravate airway inflammation. The bacterial-detection
rate (especially M. pneumoniae) was high among
wheezing children. Further research on infants with re-
fractory wheezing is needed to develop specific inflam-
matory markers.
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